A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma
暂无分享,去创建一个
P. Wen | D. Schiff | J. Raizer | D. Reardon | I. Helenowski | F. Iwamoto | B. Purow | S. Grimm | P. Kumthekar | M. Chamberlain | Roxanne T Aleman | Demirkan B Gursel | Masha Kocherginski